WEST PHARMACEUTICAL SERVICES, INC. (WST) Gross margin 2016–2025
WEST PHARMACEUTICAL SERVICES, INC. (WST) gross margin by fiscal year — reported gross profit divided by reported revenue.
35.9%FY2025 · since FY2016: 33.2% → 35.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 35.9% | +1.4 pp |
| FY2024 | 34.5% | -3.8 pp |
| FY2023 | 38.3% | -1.1 pp |
| FY2022 | 39.4% | -2.2 pp |
| FY2021 | 41.5% | +5.8 pp |
| FY2020 | 35.8% | +2.8 pp |
| FY2019 | 32.9% | +1.2 pp |
| FY2018 | 31.8% | -0.3 pp |
| FY2017 | 32.1% | -1.2 pp |
| FY2016 | 33.2% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice